|This article needs additional citations for verification. (February 2013)|
|This article relies too much on references to primary sources. (February 2013)|
Alfred Woelbing began experimenting with creating his own line of lip balm and other cosmetic products in the early 1930s in Wisconsin. These were the beginnings of Carma Laboratories, Inc. After experimenting with his products, Woelbing created Carmex on his family's stove top. He began by selling the product from the trunk of his car. Popularity increased through word-of-mouth. During this time Woelbing and his wife poured their lip balm into the now well-known yellow-capped jars. Then in 1957, the family business moved out of the kitchen and into a rented facility in the Milwaukee suburb of Wauwatosa.
After doing business like this, in 1972 Woelbing discontinued making sales calls, which had mostly been in Wisconsin, Illinois and parts of Indiana. Woelbing's son Don joined the business in 1973 and introduced assembly lines to Carma Labs. In 1975, due to the product's success, a new production facility was built in the southwest suburb of Franklin; production at the same facility continues to the present day. The company employs about 100 people. It remains under the ownership of the founding family.
Carma Labs began producing the product in squeezable tubes in 1988. In 1989 it began producing it in stick form which had been the longtime form factor for ChapStick and Blistex, Carma's major competitors in the lip balm market. After these expansions within the company's production, in 1993, it was estimated that 9% of the lip balm market was held by Carma Labs. Alfred Woelbing continued to drive to the offices every day until 1997 when he suffered a stroke. He continued to come into the office at least once a week after this, until he died in 2001 at age 100.
The company continued further expansion under the management of Alfred's son Don and grandsons Paul and Eric. In 2002, mint-flavored Carmex lip balm (SPF 30) joined original Carmex lip balm in the product line, and Carmex lip balm became available throughout North America, Australia, Europe, Asia and Africa. During 2006, Internet voters chose strawberry and cherry as the newest Carmex lip balm sticks.
In the United States, the active ingredients of Carmex lip balm are camphor (1.7%), menthol (0.7%), salicylic acid, and phenol (0.4%). The inactive ingredients, in order of greatest used to least used in the product, are petrolatum, lanolin, cetyl esters, paraffin wax, cocoa butter, beeswax, and flavor. However, this formula varies slightly around the world. For example, phenol is not included in Germany. The use of phenol in cosmetics is prohibited in the European Union.
Salicylic acid is a non-steroidal anti-inflammatory drug (NSAID) almost identical to aspirin. In fact, aspirin's mechanism of action as an NSAID results from it being metabolized into salicylic acid. It is often incorrectly thought to be a drying agent; however, this is not true. Salicylic acid works as a keratolytic, comedolytic, and bacteriostatic agent, causing the cells of the epidermis to shed more readily, opening clogged pores and neutralizing bacteria within, preventing pores from clogging up again by constricting pore diameter, and allowing room for new cell growth.
- Paulsen, Eric (29 January 2004). "Made in Milwaukee". onmilwaukee.com.
- "Carmex History". Carma Labs Inc. Retrieved October 25, 2014.
- "Major Private-Sector Employers" (PDF). ECONOMIC PROFILE: City of Franklin, WI. Franklin, Wisconsin: City of Franklin. March 19, 2012. Retrieved October 25, 2014.
- "About Us". Carma Labs Inc. Retrieved October 25, 2014.
- "Carma Laboratories, Inc. History". FundingUniverse. 2004.
- Scheuing, Kristen (2011). "The man behind Carmex: Paul Woelbing continues to diversify the popular lip balm". Wisconsin Trails (March/April 2011).
- Staff writers. "How it works". Carma Laboratories. Retrieved 2009-08-05.
- Staff writers. "Inhaltsstoffe". Carmex Deutschland. Retrieved 2011-10-24.
- "Anti-Inflammatory Activity of Aspirin – It's All About Salicylic Acid". American Chemical Society.
- Madan, RK; Levitt, J (April 2014). "A review of toxicity from topical salicylic acid preparations". J Am Acad Dermatol 70 (4): 788–92. doi:10.1016/j.jaad.2013.12.005. PMID 24472429.
- "Salicylic Acid" at kaviskin.com
- Bosund, I.; Erichsen, I.; Molin, N. (1960). "The Bacteriostatic Action of Benzoic and Salicylic Acids". Physiologia Plantarum (VI. Influence of Amino Acids and Related Substances on the Growth Inhibition) 13.4: 800–11. doi:10.1111/j.1399-3054.1960.tb08103.x.